Target intelligence / Profile preview

Tissue T2 relaxation time (T2 (when referring specifically to relaxation time in tissue environments))

Target
T2 (when referring specifically to relaxation time in tissue environments)
Molecular classification
Other (physical property, not a molecule/receptor/protein/enzyme)
01

Overview

**Tissue T2 relaxation time** represents the time constant measuring the **exponential decay of transverse magnetization** (Mxy) following excitation of tissue protons in MRI/NMR. It reflects the degree to which water protons lose phase coherence due to interactions (dipole-dipole, local field effects) within their microenvironment. T2 relaxation is generally **more rapid in solid/dense tissues** and **slower in fluids**, providing diagnostic contrast for imaging—tissues with long T2s (water/CSF, tumor, edema) appear bright on T2-weighted MRI, while those with short T2s (bone, tendons) appear dark[1][2][5][9]. T2 values vary systematically by tissue type and pathology, and changes in tissue T2 may indicate disease processes such as neuropathy, edema, or demyelination. Measurement is performed noninvasively, enabling quantification of tissue health and microstructure[3][5][9]. T2 should not be confused with T2*, which additionally reflects magnetic field inhomogeneities[4][6][8].

Other names
T2 relaxation timeSpin–spin relaxation timeTransverse relaxation timeT2 MRI signal parameter
02

Biological functions

Other (reflects molecular environment, water content, and microstructural organization in tissues[1][3][5][9])
03

Disease associations

Other (used as an imaging biomarker for detecting and characterizing disease, such as neuropathies[3], edema, tumors, inflammation, demyelination, and other tissue pathologies)
04

Safety considerations

Not applicable (not a drug target; no direct safety concerns, though accurate quantification may be affected by technical or patient-related MRI limitations)
05

Biomarkers

Tissue T2 relaxation time is routinely used as an **imaging biomarker** in MRI for: - Detecting edema/inflammation - Characterizing demyelinating diseases - Tracking tumor response or tissue degeneration[3][5][9]

Beyond the preview

Go deeper on Tissue T2 relaxation time (T2 (when referring specifically to relaxation time in tissue environments)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue T2 relaxation time (T2 (when referring specifically to relaxation time in tissue environments)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call